Impact BioMedical Inc.
IBO
$0.6439
$0.03195.21%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 215.89% | 66.89% | 361.72% | 65.29% | -53.28% |
| Depreciation & Amortization | 3.23% | 1.07% | -0.36% | 0.36% | -0.36% |
| Other Operating Expenses | 816.67% | 3,733.33% | 11.88% | 650.00% | 200.00% |
| Total Operating Expenses | 85.30% | 31.00% | -23.18% | 4.55% | -37.90% |
| Operating Income | -84.19% | -31.00% | 23.18% | -4.55% | 37.90% |
| Income Before Tax | -1,523.53% | -28.06% | -2,049.09% | 460.32% | 21.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,523.53% | -28.06% | -2,051.70% | 460.32% | 21.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 220.00% | -69.44% | -3.85% | -60.00% | -126.32% |
| Net Income | -1,513.72% | -31.70% | -2,094.98% | 465.49% | 19.33% |
| EBIT | -84.19% | -31.00% | 23.18% | -4.55% | 37.90% |
| EBITDA | -84.16% | -31.21% | 23.29% | -4.46% | 37.87% |
| EPS Basic | -1,224.30% | -9.15% | -5,521.24% | 2,337.58% | -469.87% |
| Normalized Basic EPS | -1,218.28% | -11.05% | -258.53% | 2,363.73% | -475.26% |
| EPS Diluted | -1,211.11% | -10.00% | -4,868.99% | 400.00% | -350.00% |
| Normalized Diluted EPS | -1,218.28% | -11.05% | -258.53% | 461.76% | -475.26% |
| Average Basic Shares Outstanding | 21.89% | 20.63% | -60.99% | -83.68% | -85.82% |
| Average Diluted Shares Outstanding | 21.89% | 20.63% | -60.99% | 2.13% | -85.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |